Role of p53 in transcriptional repression of SVCT2

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Molecular Biology Reports

• Publication date

  2021-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11033-021-06179-2PMID 33580460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate

  2020cited by this paper
• Ascorbate as an Enzyme Cofactor

  2020cited by this paper
• Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1

  2019cited by this paper
• Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence

  2018cited by this paper
• Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression

  2018cited by this paper
• Ascorbate regulates haematopoietic stem cell function and leukaemogenesis

  2017cited by this paper
• Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.

  2017cited by this paper
• Vitamin C Transporters in Cancer: Current Understanding and Gaps in Knowledge

  2017cited by this paper
• NIAM, a novel activator of p53 and potential tumor suppressor

  2015cited by this paper
• p53 Acetylation: Regulation and Consequences

  2014cited by this paper
• Activation of p53 Transcriptional Activity by SMRT: a Histone Deacetylase 3-Independent Function of a Transcriptional Corepressor

  2014cited by this paper
• SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment

  2013cited by this paper
• Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer

  2013cited by this paper
• p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb.

  2011cited by this paper
• A common gain of function of p53 cancer mutants in inducing genetic instability

  2010cited by this paper
• Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation

  2010cited by this paper
• Transcriptional regulation by p53.

  2010cited by this paper
• Blinded by the Light: The Growing Complexity of p53.

  2009cited by this paper
• ZBTB2, a Novel Master Regulator of the p53 Pathway*

  2009cited by this paper
• Cytoplasmic functions of the tumour suppressor p53

  2009cited by this paper
• A Novel POK Family Transcription Factor, ZBTB5, Represses Transcription of p21CIP1 Gene*

  2009cited by this paper
• SVCT1 and SVCT2: key proteins for vitamin C uptake

  2008cited by this paper
• Versatile functions of p53 protein in multicellular organisms

  2007cited by this paper
• Structural basis of DNA recognition by p53 tetramers.

  2006cited by this paper
• Transcriptional repression mediated by the p53 tumour suppressor

  2003cited by this paper
• Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

  1999cited by this paper
• Transcriptional Regulation by p53

  1995cited by this paper

• Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells

  2025influential citation
• Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2

  2023influential citation
• TCOF1 promotes the colorectal cancer progression by stabilizing β-catenin

  2023cites this paper
• HMBA ameliorates obesity by MYH9‐ and ACTG1‐dependent regulation of hypothalamic neuropeptides

  2023cites this paper
• Limited Association Between Ascorbate Concentrations and Vitamin C Transporters in Renal Cell Carcinoma Cells and Clinical Samples.

  2021cites this paper
• Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer.

  2021cites this paper